Idiocy. The FDA and Novocure people responsible for saying expected 13% alive at five years in their phase three Optune EF-14 final analysis treatment group should be sent packing. Only 12% (number = 57 out of 466) were alive at two years after the last patient’s enrollment. Only 3.4% ( number=16 of 466) had made it to five years by two years after last enrollment and most of those 16 likely were part of the 57 still alive. It’s downright criminal.